← Every applicant
Adaptis FDA Approvals
23 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| KETOROLAC TROMETHAMINENew drugSep 25, 2026INJECTABLE, INJECTION |
| PROPOFOLNew drugJul 14, 2026INJECTABLE, INJECTION |
| MAGNESIUM SULFATENew drugJul 9, 2026SOLUTION, INTRAMUSCULAR, INTRAVENOUS |
| BUPIVACAINE HYDROCHLORIDENew drugApr 22, 2026INJECTABLE, INJECTION |
| OLANZAPINENew drugMar 5, 2026POWDER, INTRAMUSCULAR |
| BUMETANIDENew drugFeb 26, 2026INJECTABLE, INJECTION |
| NOREPINEPHRINE BITARTRATENew drugNov 25, 2025INJECTABLE, INJECTION |
| LEVETIRACETAMNew drugNov 21, 2025SOLUTION, ORAL |
| POTASSIUM CHLORIDENew drugJul 11, 2025FOR SOLUTION, ORAL |
| SODIUM BICARBONATENew drugJun 26, 2025SOLUTION, INTRAVENOUS |
| VARENICLINE TARTRATENew drugApr 8, 2025TABLET, ORAL |
| LIDOCAINE HYDROCHLORIDENew drugApr 2, 2025INJECTABLE, INJECTION |
| ROPIVACAINE HYDROCHLORIDENew drugMar 21, 2025SOLUTION, INJECTION |
| CALCIUM ACETATENew drugMar 13, 2023CAPSULE, ORAL |
| POTASSIUM CHLORIDENew drugDec 30, 2022SOLUTION, ORAL |
| PREGABALINNew drugJul 18, 2022CAPSULE, ORAL |
| DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUMNew drugJun 27, 2022SOLUTION, ORAL, RECTAL |
| AMANTADINE HYDROCHLORIDENew drugMay 27, 2022TABLET, ORAL |
| DOXEPIN HYDROCHLORIDENew drugApr 19, 2022CAPSULE, ORAL |
| DROXIDOPANew drugNov 1, 2021CAPSULE, ORAL |
| AMINOCAPROIC ACIDNew drugJun 14, 2021TABLET, ORAL |
| VIGABATRINNew drugMay 13, 2021FOR SOLUTION, ORAL |
| VENLAFAXINE HYDROCHLORIDENew drugJan 21, 2021TABLET, EXTENDED RELEASE, ORAL |